NIH-funded research R01 grant

Improving colorectal cancer screening for people with Lynch Syndrome

Official title: Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype

Funded at Columbia University Health Sciences · NIH-10894888 · Data updated 2026-11-12

This study is looking to improve colorectal cancer screening for people with Lynch Syndrome by creating personalized recommendations based on their unique genetic makeup, so they can get the right care without unnecessary procedures.

More Colorectal Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 1, 2021
Project endJuly 31, 2026
Funding year2024
Award (this year)$353,665
NIH project number5R01CA257333-04
Project IDNIH-10894888 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Lynch Syndrome who are at high risk for colorectal cancer.

Less likely to help

Patients without Lynch Syndrome or those at average risk for colorectal cancer may not benefit from this research.

What this research studies

This research aims to enhance colorectal cancer (CRC) screening strategies specifically for individuals with Lynch Syndrome, a genetic condition that significantly increases the risk of developing CRC. The study will investigate how to tailor screening recommendations based on the specific genetic profile of each patient, rather than applying a uniform approach. By analyzing the varying risks associated with different genotypes, the research seeks to reduce unnecessary procedures and improve the quality of life for patients. The findings could lead to more personalized and effective surveillance strategies that align with individual risk levels.

Why it matters

Potential benefit: If successful, this research could lead to more effective and personalized colorectal cancer screening, reducing unnecessary procedures and improving patient quality of life.

How similar studies have gone: Previous research has shown that personalized screening approaches can improve outcomes in other hereditary cancer syndromes, suggesting potential success for this tailored strategy.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Hur, Chin — Columbia University Health Sciences
  • Study coordinator: Hur, Chin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.